Exosomal Long Noncoding RNAs: Insights into Emerging Diagnostic and Therapeutic Applications in Lung Cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Lung cancer is a leading cause of cancer mortality globally, often due to late diagnosis and limited treatment efficacy.
• Exosomes, extracellular vesicles involved in intercellular communication, are emerging as critical players in cancer progression and metastasis.
• Exosomal contents, including long noncoding RNAs (lncRNAs), are gaining attention for their roles in cancer biology.

Purpose of the Study:

• To review the potential of exosomal long noncoding RNAs (lncRNAs) as biomarkers for lung cancer.
• To explore the therapeutic applications of exosomal lncRNAs in lung cancer treatment.
• To discuss the advantages of utilizing exosomal lncRNAs in the context of lung cancer diagnosis and therapy.

Main Methods:

• Literature review of studies investigating exosomes and lncRNAs in lung cancer.
• Analysis of research on the diagnostic and therapeutic potential of exosomal lncRNAs.
• Synthesis of findings regarding the oncogenic and tumor-suppressive functions of lncRNAs within exosomes.

Main Results:

• Exosomes facilitate the transfer of oncogenic material between cells, contributing to lung cancer spread.
• Exosomal lncRNAs exhibit potential as sensitive and specific biomarkers for early lung cancer detection.
• Exosomal lncRNAs can be engineered for targeted drug delivery, offering a novel therapeutic strategy for lung cancer.

Conclusions:

• Exosomal lncRNAs represent a promising frontier for advancing lung cancer diagnostics and therapeutics.
• Further research into exosomal lncRNA mechanisms and clinical applications is warranted.
• Targeting exosomal lncRNAs could overcome limitations of current lung cancer treatment strategies.